Does TEPROTUMUMAB-TRBW Cause Concomitant disease aggravated? 97 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Concomitant disease aggravated have been filed in association with TEPROTUMUMAB-TRBW. This represents 2.0% of all adverse event reports for TEPROTUMUMAB-TRBW.
97
Reports of Concomitant disease aggravated with TEPROTUMUMAB-TRBW
2.0%
of all TEPROTUMUMAB-TRBW reports
1
Deaths
9
Hospitalizations
How Dangerous Is Concomitant disease aggravated From TEPROTUMUMAB-TRBW?
Of the 97 reports, 1 (1.0%) resulted in death, 9 (9.3%) required hospitalization.
Is Concomitant disease aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEPROTUMUMAB-TRBW. However, 97 reports have been filed with the FAERS database.
What Other Side Effects Does TEPROTUMUMAB-TRBW Cause?
Muscle spasms (998)
Fatigue (704)
Tinnitus (524)
Headache (443)
Hypoacusis (430)
Diarrhoea (408)
Nausea (407)
Blood glucose increased (401)
Alopecia (390)
Pain (344)
What Other Drugs Cause Concomitant disease aggravated?
SACUBITRIL\VALSARTAN (533)
SECUKINUMAB (461)
FINGOLIMOD (425)
MACITENTAN (286)
OMALIZUMAB (186)
SELEXIPAG (166)
METHOTREXATE (150)
RUXOLITINIB (142)
OCTREOTIDE (125)
BOSENTAN (123)
Which TEPROTUMUMAB-TRBW Alternatives Have Lower Concomitant disease aggravated Risk?
TEPROTUMUMAB-TRBW vs TERAZOSIN
TEPROTUMUMAB-TRBW vs TERAZOSIN\TERAZOSIN
TEPROTUMUMAB-TRBW vs TERBINAFINE
TEPROTUMUMAB-TRBW vs TERBINAFINE\TERBINAFINE
TEPROTUMUMAB-TRBW vs TERBUTALINE